3688 |
INTEGRIN SUBUNIT BETA 1 |
ITGB1 |
CD29 |
FNRB |
GPIIA |
MDF2 |
MSK12 |
VLA-BETA |
VLAB |
135630 |
6153 |
ENSG00000150093 |
OTTHUMG00000017928 |
P05556 |
ITB1_HUMAN |
INTEGRIN BETA-1 |
INTEGRIN BETA-1 PRECURSOR (FIBRONECTIN RECEPTOR BETA SUBUNIT) (CD29 ANTIGEN) (INTEGRIN VLA-4 BETA SUBUNIT). [SOURCE:UNIPROT/SWISSPROT;ACC:P05556] |
CD_antigen=CD29 |
VLA-4 subunit beta |
Glycoprotein IIa |
Fibronectin receptor subunit beta |
T01851 |
Target Class | Receptors |
Target Subclass | Receptors |
Target Subclass | Integrin |
Interpro Acc | IPR002369 |
Human Readable Name | DRUGGABLE GENOME |
Interpro Type | Domain |
Interpro Name | Integrin beta subunit, N-terminal |
Uniprot Evidence | 1: Evidence at protein level |
Interpro Short Name | Integrin_bsu_N |
Uniprot Status | Swiss-Prot |
Gene Biotype | PROTEIN_CODING |
CELL SURFACE |
TUMOR SUPPRESSOR |
KINASE |
EXTERNAL SIDE OF PLASMA MEMBRANE |
DRUGGABLE GENOME |
antibody (inhibitory) |
antagonist (inhibitory) |
Direct Interaction | yes |
Mechanism of Interaction | Integrin alpha-5/beta-1 antagonist |
Notes | Targets ALPHA-5/BETA-1 INTEGRIN |
antagonist (inhibitory) |
Trial Name | SB-683699, T-0047 |
Novel drug target | Established target |
Mechanism of Interaction | Integrin alpha-4/beta-1 antagonist |
antibody (inhibitory) |
Notes | Targets ALPHA-5/BETA-1 INTEGRIN |
n/a |
Trial Name | SAN-300 |
Novel drug target | Established target |
antibody (inhibitory) |
inhibitor (inhibitory) |
Direct Interaction | yes |
Mechanism of Interaction | Integrin alpha-4/beta-1 inhibitor |
antibody (inhibitory) |
Notes | Targets ALPHA-5/BETA-1 INTEGRIN |
antagonist (inhibitory) |
Mechanism of Interaction | Integrin alpha-V/beta-1 antagonist |
Direct Interaction | yes |
inhibitor (inhibitory) |
Direct Interaction | yes |
Mechanism of Interaction | Integrin alpha-V/beta-1 inhibitor |
n/a |
Trial Name | GLPG0187 |
Novel drug target | Established target |
ITGB1 | Ensembl Gene Name |
Gene Biotype | PROTEIN_CODING |
ITGB1 | Gene Symbol |
Target Class | Receptors |
Target Subclass | Receptors |
Target Subclass | Integrin |
ITGB1 | Display Id |
INTEGRIN BETA-1 PRECURSOR (FIBRONECTIN RECEPTOR BETA SUBUNIT) (CD29 ANTIGEN) (INTEGRIN VLA-4 BETA SUBUNIT). [SOURCE:UNIPROT/SWISSPROT;ACC:P05556] | Description |
ENSG00000150093 | Ensembl Gene Id |
Human Readable Name | DRUGGABLE GENOME |
DRUGGABLE GENOME |
ITGB1 | Uniprot Gene Name |
ENSG00000150093 | Ensembl Gene Id |
ITB1_HUMAN | Uniprot Id |
Interpro Acc | IPR002369 |
Human Readable Name | DRUGGABLE GENOME |
Interpro Type | Domain |
DRUGGABLE GENOME |
ENSG00000150093 | Gene Symbol |
ITGB1 | Ensembl Id |
DRUGGABLE GENOME |
ITGB1 | Gene Symbol |
MDF2 | GENE_SYMBOL |
MSK12 | GENE_SYMBOL |
ITGB1 | GENE_SYMBOL |
FNRB | GO Gene Synonym |
MDF2 | GO Gene Synonym |
MSK12 | GO Gene Synonym |
CELL SURFACE, TUMOR SUPPRESSOR, EXTERNAL SIDE OF PLASMA MEMBRANE |
ITGB1 | TTD Gene Abbreviation |
T01851 | TTD Target ID |
Integrin beta-1 | Gene Name |
P05556 | UniProt ID |
KINASE |